GenVec to Release Second Quarter 2011 Financial Results and Conduct a Conference
Call on August 9, 2011
GAITHERSBURG, Md., Aug. 2, 2011 /PRNewswire via COMTEX/ -- GenVec, Inc. (GNVC)
will report financial results for the second quarter of 2011 on Tuesday, August
9, 2011, before the U.S. financial markets open. The announcement will be
followed by a webcast and conference call at 10:00 a.m. EDT to discuss the
company's second quarter financial results and business outlook.
To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada)
or 706-643-4980 (international) and use the following Conference ID: 84527868. An
audio replay of the conference call will be available starting at 1:00 p.m. EDT
on August 9, 2011 through August 16, 2011. To listen to the audio replay, dial
855-859-2056 or 404-537-3406 and use Conference Replay ID: 84527868.
To access the webcast or the replay, go to genvec.com, click on
"Investors and Media," and click on "Events and Presentations."
About GenVec
GenVec, Inc. is a biopharmaceutical company using superior, proprietary
technology to create differentiated vaccines and therapeutics that are developed
and commercialized through collaborations. GenVec is working with leading
companies and organizations such as Novartis, Merial, and the US Government to
support a portfolio of product programs that address the prevention and treatment
of a number of significant human and animal health concerns. GenVec's development
programs address therapeutic areas such as hearing loss, balance disorders, and
cancer; as well as vaccines against infectious diseases including respiratory
syncytial virus (RSV), HSV-2, dengue fever, influenza, HIV, malaria, and
foot-and-mouth disease. Additional information about GenVec is available at
genvec.com and in the Company's various filings with the Securities
and Exchange Commission.
Retail Investor and Media Contact: Institutional Investor Contact:
GenVec, Inc.S.A. Noonan Communications
Douglas J. SwirskySusan A. Noonan
(240) 632-5510(212) 966-3650
dswirsky@genvec.comsusan@sanoonan.com |
